Insud Pharma - About the company
Insud Pharma is a funded company based in Madrid (Spain), founded in 1977 by Hugo Sigman. It operates as a Developer and manufacturer of finished formulations, APIs and monoclonal antibodies. Insud Pharma has raised an undisclosed amount in funding. The company has 331 active competitors, including 22 funded and 98 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Aragen.
Company Details
Insud Pharma develops and manufactures finished dosage forms (FDFs), active pharmaceutical ingredients (APIs), and monoclonal antibodies to fight cancer and autoimmune diseases. The company operates through three business areas, API production(Chemo), branded generics (Exeltis) and biologics (mAbxience). They mainly focus on therapeutic areas including cardiovascular, gastroenterology, central nervous system, anti-infective, respiratory, women's health, endocrinology, dermatology, and urology.
- Website
- www.insudpharma.com/
- Email ID
- *****@insudpharma.com
- Phone Number
- +34 **********
- Registered Address
- 5/2, Industrial Area, Kirti Nagar, West Delhi, New Delhi, Delhi, India, 110015
Key Metrics
Founded Year
1977
Location
Madrid, Spain
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
19th among 331 active competitors
Employee Count
7,228 as on Aug 31, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Insud Pharma
Insud Pharma is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
INDUS PHARMA PRIVATE LIMITED CIN: U74899DL1987PTC026657 , India, Active | Jan 12, 1987 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | 12 (As on Aug 31, 2025) |
Sign up to download Insud Pharma's company profile
Insud Pharma's funding and investors
Insud Pharma has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Nov 22, 2024 for $*****. 1 investor participated in its latest round. Insud Pharma has 1 institutional investor.
Here is the list of recent funding rounds of Insud Pharma:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 22, 2024 | 3743211 | Grant (prize money) | 8828477 | 5604394 | 6632905 | 6177887 |
View details of Insud Pharma's funding rounds and investors
Insud Pharma's founders and board of directors
Founder? Claim ProfileThe founders of Insud Pharma is Hugo Sigman.
Here are the details of Insud Pharma's key team members:
- Hugo Sigman: Co-Founder of Insud Pharma.
View details of Insud Pharma's Founder profiles and Board Members
Insud Pharma's employee count trend
Insud Pharma has 7,228 employees as of Aug 26. Here is Insud Pharma's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Insud Pharma's Competitors and alternates
Top competitors of Insud Pharma include Anthem Biosciences, Patheon and Aragen. Here is the list of Top 10 competitors of Insud Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Anthem Biosciences 2006, Bengaluru (India), Public | Developer of integrated contract research development and manufacturing services | $35.7M | 77/100 | |
2nd | Patheon 1974, Durham (United States), Acquired | Global CDMO providing integrated drug development, clinical trials, and manufacturing services | $141M | 74/100 | |
3rd | Provider of drug discovery, clinical development, manufacturing, and other services for small molecules | $161M | 69/100 | ||
4th | KBI Biopharma 1996, Durham (United States), Acquired | Provider of protein formulation, process & cell line development, and cGMP services | $21M | 68/100 | |
5th | Provider of contract research and manufacturing services for both small molecules and biologics | $85.9M | 66/100 | ||
6th | Abzena 2001, Cambridge (United Kingdom), Acquired | Provider of antibody discovery, cell line development, and bio analytics services | $67.1M | 66/100 | |
7th | Abingdon Health 2008, York (United Kingdom), Public | Developer of immunoassays for diagnostic purposes | $24.1M | 64/100 | |
8th | Panacea Biotec 1984, Ambala (India), Public | Developer of biosimilars, vaccines and natural products | - | 62/100 | |
9th | Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired | Aseptic manufacturing CDMO providing fill-finish services for sterile injectables | $16.9M | 59/100 | |
10th | Contract development and manufacturing organization for biologics | - | 58/100 | ||
19th | Insud Pharma 1977, Madrid (Spain), Funding Raised | Developer and manufacturer of finished formulations, APIs and monoclonal antibodies | - | 53/100 |
Looking for more details on Insud Pharma's competitors? Click here to see the top ones
Insud Pharma's Investments and acquisitions
Insud Pharma has made 5 investments in companies including Procaps Group and Procaps Group. Insud Pharma has also acquired 3 companies including Agile Therapeutics and Viatris.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Apr 09, 2025 | Investments | 1999 | Miami (United States) | |
Aug 26, 2024 | Acquisition | 1997 | Princeton (United States) | |
Mar 16, 2024 | Acquisition | 1998 | Frankfurt (Germany) |
See all investments by Insud Pharma
Reports related to Insud Pharma
Here is the latest report on Insud Pharma's sector:
News related to Insud Pharma
Media has covered Insud Pharma for 1 event in last 1 year, It was about people movement.
•
Insud Pharma to invest 100 million in its Alcala (Madrid) center and create 100 jobsPressDigital•Mar 06, 2026•Insud Pharma
•
Insud Pharma Receives $2.7M Gates Foundation Grant to Develop Sublingual Oxytocin for Postpartum HemorrhageFemtech Insider•Nov 22, 2024•Insud Pharma, Gates
•
•
•
•
Agile Therapeutics to be acquired by Spain-based Insud for an enterprise value of ~$45MSeeking Alpha•Jun 26, 2024•Agile Therapeutics, Insud Pharma, Exeltis
•
•
An Argentine company became the largest contraceptive manufacturer in the worldesdelatino.com•Mar 16, 2024•Insud Pharma, Viatris
•
•
Are you a Founder ?
FAQs about Insud Pharma
Explore our recently published companies
- Entekhaabco - Kuwait City based, 2019 founded, Unfunded company
- Glovnetics - Gurugram based, 2022 founded, Unfunded company
- NoBuzz - Pretoria based, 2017 founded, Unfunded company
- Tantrayut - Ambernath based, 2015 founded, Unfunded company
- Ningbo Dayang Technology - Ningbo based, 2010 founded, Unfunded company
- Good Riddance Insect Repellent - Mitcham based, 2014 founded, Unfunded company
